Needle-in-Tumor cancer therapy seeks to rally Body's defenses
Disease control
Not yet recruiting
This study is testing an experimental drug called N17350 for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The drug is injected directly into a tumor every two weeks to try to stimulate the immune system to fight the cancer. The …
Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC